Potential complication associated with removal of ganciclovir implants

American Journal of Ophthalmology

Volumn 127, Issue 3, 1999, Pages 349-350

  Boyer, David S ^a   Posalski, Jana ^a  

^a RETINA VITREOUS ASSOCIATES MEDICAL GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ADULT; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DEVICE; DRUG IMPLANT; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINITIS; SURGICAL TECHNIQUE; TREATMENT FAILURE;

EID: 0033104542     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(98)00176-7     Document Type: Article

References (5)

1. Martin D.F., Parks D.J., Mellow S.D., et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant a randomized controlled clinical trial. Arch Ophthalmol. 112:1994;1531-1539.
2. Sanborn G.E., Anand R., Torti E., et al. Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis use of an intravitreal device. Arch Ophthalmol. 110:1992;188-195.
3. Chiron Vision Corporation Cytomegalovirus retinopathy in patients with the acquired immunodeficiency syndrome: advantages of localized therapy with a ganciclovir-releasing sterile intravitreal implant (Vitrasert). Claremont, California, August 1996.
4. Martin DF, Kupperman BD. Intravitreal Drug Delivery Implant: Implantation and Re-implantation Procedure. Claremont, California, Chiron Vision Corporation, December 1996. Videotape.
5. Martin D.F., Ferris F.L., Parks D.J., et al. Ganciclovir implant exchange timing, surgical procedures, and complications. Arch Ophthalmol. 115:1997;1389-1394.